R 156 Pill - pink round, 11mm
Pill with imprint R 156 is Pink, Round and has been identified as Ondansetron Hydrochloride 24 mg. It is supplied by Dr. Reddy’s Laboratories Inc.
Ondansetron is used in the treatment of Nausea/Vomiting; Nausea/Vomiting, Postoperative; Nausea/Vomiting, Chemotherapy Induced; Nausea/Vomiting, Radiation Induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 24 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R 156
Ondansetron Hydrochloride
- Imprint
- R 156
- Strength
- 24 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- 5HT3 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC)
- 55111-0156
- Inactive Ingredients
-
silicon dioxide,
hypromellose 2910 (6 mPa.s),
ferric oxide red,
ferrosoferric oxide,
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Submitted by: picoblue
Related images for "R 156"
More about ondansetron
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (483)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: 5HT3 receptor antagonists
- Breastfeeding
Patient resources
- Ondansetron drug information
- Ondansetron injection
- Ondansetron (Injection) (Advanced Reading)
- Ondansetron (Oral, Oromucosal) (Advanced Reading)
- Ondansetron Oral Soluble Film
Other brands
Professional resources
- Ondansetron monograph
- Ondansetron (FDA)
- Ondansetron Injection (FDA)
- Ondansetron ODT (FDA)
- Ondansetron Oral Solution (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
